PMC:7736111 / 92366-92662 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"2243","span":{"begin":35,"end":43},"obj":"Species"},{"id":"2244","span":{"begin":247,"end":255},"obj":"Species"},{"id":"2245","span":{"begin":279,"end":287},"obj":"Species"}],"attributes":[{"id":"A2243","pred":"tao:has_database_id","subj":"2243","obj":"Tax:9606"},{"id":"A2244","pred":"tao:has_database_id","subj":"2244","obj":"Tax:9606"},{"id":"A2245","pred":"tao:has_database_id","subj":"2245","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"In line with the post-mortem data, patients with severe disease condition (n = 25) had a significant decrease in the number of naïve B cells, CD19+ B cells, and follicular B cell subsets in comparison to the healthy controls (n = 4), convalescent patients (n = 39), and moderate patients (n = 4)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T543","span":{"begin":0,"end":296},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In line with the post-mortem data, patients with severe disease condition (n = 25) had a significant decrease in the number of naïve B cells, CD19+ B cells, and follicular B cell subsets in comparison to the healthy controls (n = 4), convalescent patients (n = 39), and moderate patients (n = 4)."}